This review concluded that most patients with coeliac disease can tolerate oats, but that the long-term safety of taking oats is unknown. The included studies appear to have methodological limitations and this, in combination with poor reporting of review methods, means that these conclusions, although cautious, may not be reliable.
Results of the review
Five studies (reported in six papers) were included (n=362). One of the studies was a randomised controlled trial (n=92); the design of the other studies was not clear.
Study quality was reported for the six reports of the five included studies. The studies scored from 0 to 7.5 out of 10 for randomisation; one report scored maximum points for blinding; scores for withdrawals and drop-outs ranged from 4 to 14 out of 24; three reports scored maximum points for compliance; and five reports scored maximum points for outcome measures.
None of the four reports that measured the ratio of villous height to crypt depth reported any significant difference between patients on GRD taking oats and patients not taking oats.
Four of the six reports that measured intraepithelial lymphocytes reported no significant difference between patients on GRD taking oats and patients not taking oats. The other two studies reported significantly higher intraepithelial lymphocyte counts in patients taking oats than in control patients (p<0.001 and p=0.039, respectively).
None of the five studies that measured serology reported any significant difference in various measures of serology between patients on GRD taking oats and patients not taking oats.
Two of the three studies that used the GSRS reported no significant difference between patients on GRD taking oats and patients not taking oats. The third study reported significantly more diarrhoea in patients taking oats than in control patients (p=0.01).
None of the studies reported any significant difference in withdrawals between patients on GRD taking oats and patients not taking oats. The most common reason for withdrawal in patients taking oats was abdominal symptoms.
Authors' conclusions
Most patients with coeliac disease can tolerate oats, but the long-term safety of taking oats is unknown.
CRD commentary
The review addressed a clear question that was defined in terms of the participants, intervention and outcomes; inclusion criteria for the study design were broad, which seemed appropriate given the limited number of studies identified. Several relevant sources were searched and attempts were made to minimise publication bias, but it was unclear whether any language restrictions had been applied. Methods were used to minimise reviewer errors and bias in the selection of studies, but it was unclear whether similar steps were taken in the assessment of validity and extraction of data. Validity was assessed using specified criteria; the results were reported as aggregated scores and were difficult to interpret in terms of relevant aspects of study design. One study appeared to use an inappropriate control group.
In view of the differences between the studies, the narrative synthesis was appropriate. However, study quality was not taken into account when summarising the studies. The included studies appear to have methodological limitations and this, in combination with incomplete reporting of review methods, means that these conclusions, although cautious, may not be reliable.
